Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

Name: Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.
Published: 2025
License: Public Domain

First Affiliated Hospital of Zhejiang University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

relapsed/refractory acute myeloid leukemia(aml), cd84 chimeric antigen receptor t-cell therapy, interventional, early_phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia.

Related documents